AVRO
$1.09
Avrobio
$.04
3.81%
AVRO
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  $0.40
Revenue:  N/A
Thursday
Aug 10
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AVRO reports earnings?
Beat
Meet
Miss

Where is AVRO's stock price going from here?
Up
Flat
Down
Stock chart of AVRO
Analysts
Summary of analysts' recommendations for AVRO
Score
Grade
Pivots
Resistance
$1.18
$1.16
$1.10

$1.08

Support
$1.02
$1.00
$0.94
Tweet
Growth
Description
Avrobio, Inc. is a bio-technology company. It develops step-change cell and gene therapies for the treatment of cancer and rare disease. The company operates primarily in the United States and Canada. Avrobio, Inc. is based in MA, United States.
›